Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9648865rdf:typepubmed:Citationlld:pubmed
pubmed-article:9648865lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:9648865lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:9648865lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:9648865lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9648865lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:9648865pubmed:issue1lld:pubmed
pubmed-article:9648865pubmed:dateCreated1998-7-9lld:pubmed
pubmed-article:9648865pubmed:abstractTextCaspase activation has been shown to be a critical step in several models of neuronal apoptosis such as staurosporine treatment of human neuroblastoma SH-SY5Y cells and potassium deprivation of rat cerebellar granule neurons. One common event is the appearance of caspase-mediated 120-kDa nonerythroid alpha-spectrin breakdown product (SBDP120). Second, inhibitors of the caspase family are effective blockers of such neuronal death. In this study, we report the appearance of caspase-mediated SBDP120 in excitotoxin-challenged fetal rat cerebrocortical neurons [N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and kainate] and rat cerebellar granule neurons (NMDA and kainate). A general caspase inhibitor, carbobenzoxy-Asp-CH2OC(O)-2,6-dichlorobenzene (Z-D-DCB), blocked the formation of SBDP120 under these conditions and attenuated the observed NMDA-induced lactate dehydrogenase (LDH) release in both cell types. Furthermore, hydrolytic activity toward a caspase-3-preferred synthetic peptide substrate, acetyl-DEVD-7-amido-4-methylcoumarin, was significantly elevated in NMDA-treated granule neurons. Lastly, oxygen-glucose deprivation (OGD)-challenged cerebrocortical cultures also showed the appearance of SBDP120. Again, Z-D-DCB blocked the SBDP120 formation as well as attenuated the LDH release from the OGD-challenged neurons. Taken together, the presence of caspase-specific SBDP120 and the neuroprotective effects of Z-D-DCB strongly suggest that caspase activation contributes at least in part to excitotoxin- and OGD-induced neuronal death.lld:pubmed
pubmed-article:9648865pubmed:languageenglld:pubmed
pubmed-article:9648865pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:citationSubsetIMlld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648865pubmed:statusMEDLINElld:pubmed
pubmed-article:9648865pubmed:monthJullld:pubmed
pubmed-article:9648865pubmed:issn0022-3042lld:pubmed
pubmed-article:9648865pubmed:authorpubmed-author:NathRRlld:pubmed
pubmed-article:9648865pubmed:authorpubmed-author:WannK TKTlld:pubmed
pubmed-article:9648865pubmed:authorpubmed-author:McGinnisK MKMlld:pubmed
pubmed-article:9648865pubmed:authorpubmed-author:ProbertAAJrlld:pubmed
pubmed-article:9648865pubmed:issnTypePrintlld:pubmed
pubmed-article:9648865pubmed:volume71lld:pubmed
pubmed-article:9648865pubmed:ownerNLMlld:pubmed
pubmed-article:9648865pubmed:authorsCompleteYlld:pubmed
pubmed-article:9648865pubmed:pagination186-95lld:pubmed
pubmed-article:9648865pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:meshHeadingpubmed-meshheading:9648865-...lld:pubmed
pubmed-article:9648865pubmed:year1998lld:pubmed
pubmed-article:9648865pubmed:articleTitleEvidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons.lld:pubmed
pubmed-article:9648865pubmed:affiliationDepartment of Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.lld:pubmed
pubmed-article:9648865pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648865lld:pubmed